Lpl Financial LLC Teva Pharmaceutical Industries LTD Transaction History

Lpl Financial LLC

$196 Billion
Q2 2024

A detailed history of Lpl Financial LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Lpl Financial LLC holds 214,286 shares of TEVA stock, worth $3.83 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

214,286

Previous 261,032 17.91%

Holding current value

$3.83 Million

Previous $3.68 Million 5.46%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$12.78 - $17.4 $597,413 - $813,380	-46,746 Reduced 17.91%	214,286 $3.48 Million
Q1 2024 May 10, 2024	BUY	$10.67 - $14.43 $419,106 - $566,795	39,279 Added 17.71%	261,032 $3.68 Million
Q4 2023 Feb 14, 2024	BUY	$8.12 - $10.63 $105,267 - $137,807	12,964 Added 6.21%	221,753 $2.32 Million
Q3 2023 Nov 13, 2023	SELL	$7.48 - $10.7 $155,539 - $222,495	-20,794 Reduced 9.06%	208,789 $2.13 Million
Q2 2023 Jul 31, 2023	SELL	$7.2 - $9.47 $257,076 - $338,126	-35,705 Reduced 13.46%	229,583 $1.73 Million
Q1 2023 May 10, 2023	SELL	$8.36 - $11.37 $31,065 - $42,250	-3,716 Reduced 1.38%	265,288 $2.35 Million
Q4 2022 Feb 07, 2023	SELL	$7.95 - $9.48 $69,681 - $83,092	-8,765 Reduced 3.16%	269,004 $2.45 Million
Q3 2022 Nov 14, 2022	BUY	$6.86 - $11.95 $129,729 - $225,986	18,911 Added 7.31%	277,769 $2.24 Million
Q2 2022 Aug 12, 2022	SELL	$7.38 - $10.4 $51,888 - $73,122	-7,031 Reduced 2.64%	258,858 $1.95 Million
Q1 2022 May 16, 2022	SELL	$7.33 - $9.39 $50,591 - $64,809	-6,902 Reduced 2.53%	265,889 $2.5 Million
Q4 2021 Feb 14, 2022	SELL	$7.9 - $10.19 $257,073 - $331,592	-32,541 Reduced 10.66%	272,791 $2.19 Million
Q3 2021 Nov 15, 2021	SELL	$8.38 - $10.18 $114,680 - $139,313	-13,685 Reduced 4.29%	305,332 $2.97 Million
Q2 2021 Aug 13, 2021	BUY	$9.9 - $11.56 $56,628 - $66,123	5,720 Added 1.83%	319,017 $3.16 Million
Q1 2021 May 14, 2021	BUY	$10.34 - $12.81 $33,966 - $42,080	3,285 Added 1.06%	313,297 $3.62 Million
Q4 2020 Feb 12, 2021	BUY	$8.61 - $11.04 $201,930 - $258,921	23,453 Added 8.18%	310,012 $2.99 Million
Q3 2020 Nov 09, 2020	SELL	$8.57 - $12.69 $312,967 - $463,426	-36,519 Reduced 11.3%	286,559 $2.58 Million
Q2 2020 Aug 13, 2020	BUY	$8.12 - $13.12 $37,563 - $60,693	4,626 Added 1.45%	323,078 $3.98 Million
Q1 2020 May 14, 2020	BUY	$6.69 - $13.45 $92,596 - $186,161	13,841 Added 4.54%	318,452 $2.86 Million
Q4 2019 Feb 14, 2020	BUY	$6.53 - $10.72 $961,013 - $1.58 Million	147,169 Added 93.48%	304,611 $2.99 Million
Q3 2019 Nov 13, 2019	SELL	$6.16 - $9.6 $64,840 - $101,049	-10,526 Reduced 6.27%	157,442 $1.08 Million
Q2 2019 Aug 09, 2019	SELL	$8.12 - $15.72 $241,383 - $467,308	-29,727 Reduced 15.04%	167,968 $1.55 Million
Q1 2019 May 08, 2019	BUY	$15.58 - $20.01 $185,433 - $238,159	11,902 Added 6.41%	197,695 $3.1 Million
Q4 2018 Feb 07, 2019	SELL	$14.59 - $23.84 $146,994 - $240,188	-10,075 Reduced 5.14%	185,793 $2.87 Million
Q3 2018 Nov 14, 2018	BUY	$21.06 - $25.65 $110,586 - $134,688	5,251 Added 2.75%	195,868 $4.22 Million
Q2 2018 Aug 14, 2018	BUY	$16.77 - $24.71 $357,167 - $526,273	21,298 Added 12.58%	190,617 $4.64 Million
Q1 2018 May 15, 2018	BUY	$16.68 - $22.07 $252,768 - $334,448	15,154 Added 9.83%	169,319 $2.89 Million
Q4 2017 Feb 14, 2018	SELL	$11.23 - $19.1 $1.04 Million - $1.76 Million	-92,392 Reduced 37.47%	154,165 $2.92 Million
Q3 2017 Nov 14, 2017	BUY	$15.41 - $32.17 $380,149 - $793,601	24,669 Added 11.12%	246,557 $4.34 Million
Q2 2017 Aug 14, 2017	BUY	N/A	221,888	221,888 $7.37 Million

Others Institutions Holding TEVA

# of Institutions

603

Shares Held

567M

Call Options Held

25.2M

Put Options Held

5.08M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.8B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Teva Pharmaceutical Industries LTD Transaction History